GRI Bio Inc.
GRI | NASDAQ
$1.53
-$0.04 (-2.55%)
At close: Oct 30, 2026, 4:00 PM ET
$1.52
-$0.01 (-0.65%)
After-hours:
Oct 30, 2026, 7:32 PM ET
Market Data
Market Cap $3.34M
Enterprise Value $-7.56M
Beta -0.61
Average Volume 247.51K
Shares Outstanding (Diluted) 1.8M
Shares Change YoY 2191.86%
Institutional Ownership 5.18%
Exchange NASDAQ
ISIN US3622AW5029
Price Performance
Price Change 1M -20.7%
Price Change 3M 10.9%
Price Change 6M -29.8%
Price Change YTD -77.9%
Price Change 1Y -96.8%
Price Change 3Y -100.0%
Price Change 5Y -100.0%
1M CAGR (ann.) -20.7%
1Y CAGR (ann.) -96.9%
5Y CAGR (ann.) -95.3%
All-Time CAGR -93.6%
Valuation
PE Ratio -0.04
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.00
PS Ratio N/A
Forward PS N/A
PB Ratio 0.33
P/FCF Ratio -0.32
P/Adj. FCF Ratio -0.30
P/OCF Ratio -0.27
EV/Sales N/A
EV/EBIT 0.78
EV/EBITDA 0.78
EV/FCF 0.73
Earnings Yield -2856.2%
FCF Yield -311.5%
Adj. FCF Yield -329.3%
Financial Health
Net Cash $10.9M
Total Debt $44K
Cash & Short-Term Investments $10.95M
Total Assets $11.38M
Current Ratio 10.30
Quick Ratio 10.30
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt -236.70
Interest Coverage 0.00
Altman Z-Score -6.71
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -5.7%
Returns
Return on Assets -84.9%
Return on Equity -134.0%
Return on Invested Capital -93.8%
Return on Capital Employed -94.2%
Return on Tangible Assets -84.9%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 148.4%
EPS CAGR 5Y 78.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y 3.8%
FCF CAGR 5Y -21.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 2
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 13, 2026
EPS Estimate (next Q) -$0.84
EPS Growth Est (next Q) -97.7%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $18.50
Price Target Upside 1109.2%
Cash Flow
Operating Cash Flow $-10.42M
Free Cash Flow $-10.42M
Adj. Free Cash Flow $-11.01M
FCF Per Share -$5.77
OCF Per Share -$5.77
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-9.68M
EBITDA $-9.68M
Net Income $-9.66M
EPS (Diluted) -$43.70
Revenue / Employee N/A
Profit / Employee $-2.41M
Employees 4
Add to Watchlist
Select watchlists to add or remove GRI